Home Data Calendar Blog

TWST

Tables

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Weighted Average Number Of Diluted Shares Outstanding		57.78	57.50	NA	57.04	56.78	56.44	NA	56.29	53.47	49.91	NA	48.96	48.71	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Weighted Average Number Of Shares Outstanding Basic		57.78	57.50	NA	57.04	56.78	56.44	NA	56.29	53.47	49.91	NA	48.96	48.71	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Basic		-0.79	-0.75	-0.81	-1.01	-1.04	-0.74	-0.89	-1.08	-1.13	-0.91	-0.83	-0.82	-0.78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Diluted		-0.79	-0.75	-0.81	-1.01	-1.04	-0.74	-0.89	-1.08	-1.13	-0.91	-0.83	-0.82	-0.78	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Revenue From Contract With Customer Including Assessed Tax		75.30	71.50	66.95	63.74	60.18	54.24	57.31	56.11	48.13	42.02	37.95	35.02	31.20	28.16	32.43	21.21	19.30	17.16	15.74	13.60	13.56	11.49	8.41	6.54	6.17	4.31
Revenues		75.30	71.50	66.95	63.74	60.18	54.24	57.31	56.11	48.13	42.02	37.95	35.02	31.20	28.16	32.43	21.21	19.30	17.16	15.74	13.60	13.56	11.49	8.41	6.54	6.17	4.31
Cost Of Revenue		44.42	42.54	42.42	41.84	41.67	29.44	31.59	30.97	29.71	27.06	22.50	20.93	19.03	18.16	17.58	16.47	13.56	13.79	12.38	11.39	11.79	11.86	9.09	7.50	8.10	7.50
Costs And Expenses		124.19	118.47	117.06	124.52	121.82	98.87	114.18	117.28	108.93	97.96	77.76	77.14	69.21	60.95	56.40	49.40	51.38	72.99	47.30	41.72	39.82	34.39	28.11	24.03	22.78	NA
Research And Development Expense		24.15	23.10	23.75	24.53	27.38	31.24	29.61	36.84	31.23	22.63	19.44	19.84	15.79	14.00	11.64	10.44	10.63	10.30	10.50	9.01	8.91	7.27	6.07	5.27	4.71	4.30
Selling General And Administrative Expense		55.62	52.84	47.39	46.06	53.97	42.32	54.16	53.69	54.00	51.10	38.24	34.48	34.39	28.79	27.18	22.49	27.19	26.41	24.42	21.32	19.12	15.26	12.95	11.26	9.98	9.26
Operating Income Loss		-48.89	-46.98	-50.11	-60.78	-61.64	-44.63	-56.87	-61.16	-60.80	-55.94	-39.81	-42.12	-38.00	-32.79	-23.97	-28.20	-32.09	-55.83	-31.57	-28.12	-26.26	-22.90	-19.70	-17.49	-16.62	-16.75
Allocated Share Based Compensation Expense		13.82	11.02	11.75	10.60	10.26	-2.33	18.77	19.86	22.34	18.07	9.25	9.18	11.55	7.02	5.13	4.07	4.20	3.70	3.36	3.03	2.91	1.86	1.09	0.60	0.74	0.54
Income Tax Expense Benefit		0.34	0.12	-0.22	0.62	0.68	0.08	0.29	-0.15	-0.15	-10.40	0.34	-2.38	0.06	0.05	0.26	0.02	0.06	0.04	0.11	0.05	0.08	0.04	0.08	0.07	0.04	0.05
Income Taxes Paid Net		0.30	0.04	0.18	0.10	0.09	0.05	0.12	0.00	0.04	0.09	0.05	0.05	-0.08	0.08	0.05	0.00	0.08	0.04	0.07	0.06	0.11	0.05	0.16	0.01	0.01	0.01
Profit Loss		-45.49	-43.01	-46.24	-57.40	-59.16	-41.82	-51.12	-60.52	-60.67	-45.56	-41.24	-40.04	-37.92	-32.90	-24.32	-28.21	-31.77	-55.64	-31.18	-27.92	-25.93	-22.64	-19.80	-17.62	-16.87	-16.94
Other Comprehensive Income Loss Net Of Tax		-0.10	0.19	-0.12	-0.75	0.72	1.23	-0.47	-0.90	-0.84	-0.18	0.12	0.24	0.05	0.06	-0.05	-0.08	0.02	0.01	0.06	0.25	-0.16	-0.06	0.02	0.01	0.01	0.01
Net Income Loss		-45.49	-43.01	-46.24	-57.40	-59.16	-41.82	-51.12	-60.52	-60.67	-45.56	-41.24	-40.04	-37.92	-32.90	-24.32	-28.21	-31.77	-55.64	-31.18	-27.92	-25.93	-22.64	-19.80	-17.62	-16.87	-16.94
Comprehensive Income Net Of Tax		-45.59	-42.82	-46.36	-58.14	-58.44	-43.06	-51.58	-61.42	-61.51	-45.38	-41.12	-39.80	-37.87	-32.84	-24.36	-28.29	-31.75	-55.63	-31.12	-27.66	-26.09	-22.70	-19.78	-17.61	-16.86	-16.93

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Assets		702.85	732.82	776.40	810.33	853.92	909.97	961.38	979.66	1021.64	786.17	702.10	725.30	677.29	699.57	398.88	408.24	323.87	192.28	186.99	206.81	140.17	164.45	115.79	NA	NA	NA
Liabilities		142.72	142.77	152.97	152.78	149.99	163.65	171.99	158.99	158.28	159.99	121.28	114.85	63.11	61.62	62.62	59.29	59.67	89.20	34.91	30.80	24.69	25.86	26.73	NA	NA	NA
Liabilities And Stockholders Equity		702.85	732.82	776.40	810.33	853.92	909.97	961.38	979.66	1021.64	786.17	702.10	725.30	677.29	699.57	398.88	408.24	323.87	192.28	186.99	206.81	140.17	164.45	115.79	NA	NA	NA
Stockholders Equity		560.13	590.04	623.43	657.55	703.93	746.33	789.38	820.68	863.36	626.18	580.82	610.45	614.18	637.95	336.26	348.95	264.20	103.08	152.08	176.00	115.48	138.60	-201.42	-182.76	-165.72	-149.70

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Assets Current		371.87	390.23	424.26	445.54	489.27	541.86	596.48	624.12	664.38	385.01	546.50	576.61	608.00	634.43	334.87	344.58	260.20	129.29	160.13	182.62	120.99	146.66	95.67	NA	NA	NA
Cash And Cash Equivalents At Carrying Value		243.35	266.27	286.47	307.46	315.20	316.68	378.69	376.25	407.63	191.62	465.83	475.28	399.33	348.79	93.67	207.85	184.40	26.03	46.73	68.21	28.69	66.46	80.76	NA	NA	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		246.22	269.12	289.28	311.84	317.56	319.09	380.26	377.82	409.20	193.20	467.36	476.81	400.86	350.32	94.25	208.52	185.06	26.95	47.40	68.98	29.49	67.09	81.54	91.10	78.63	26.29
Short Term Investments		49.99	44.88	49.94	49.69	72.46	122.03	126.28	151.34	166.23	110.23	12.03	44.13	156.33	238.50	196.34	103.91	45.67	77.08	91.37	NA	NA	NA	NA	NA	NA	NA
Accounts Receivable Net Current		35.99	35.35	44.06	42.58	48.19	44.44	40.29	41.20	34.88	32.87	28.55	28.12	27.29	25.49	26.38	13.35	14.83	13.05	12.10	11.70	8.00	6.98	5.42	NA	NA	NA
Inventory Net		30.38	30.86	32.06	36.35	39.92	44.60	39.31	43.02	44.59	40.24	31.80	21.22	15.84	13.41	12.29	13.16	10.76	7.42	7.33	5.50	4.45	5.56	6.03	NA	NA	NA
Inventory Finished Goods		5.77	4.72	3.93	4.85	5.29	7.43	7.65	8.23	9.57	6.76	8.19	NA	NA	1.77	1.03	1.38	2.02	0.87	1.27	1.13	0.42	0.61	0.77	NA	NA	NA
Prepaid Expense And Other Assets Current		12.16	12.87	11.72	9.46	13.50	14.12	11.91	12.31	11.05	10.04	8.28	7.86	9.21	8.24	6.20	6.31	4.55	5.71	2.59	3.64	4.22	3.96	3.47	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Property Plant And Equipment Gross		185.87	183.83	182.49	186.44	187.91	180.54	171.22	NA	NA	NA	79.54	NA	NA	NA	54.94	NA	NA	NA	43.83	NA	NA	NA	29.58	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		64.53	57.61	50.66	45.66	41.37	35.69	31.78	NA	NA	NA	35.42	NA	NA	NA	29.48	NA	NA	NA	22.99	NA	NA	NA	17.25	NA	NA	NA
Amortization Of Intangible Assets		1.30	1.30	1.40	1.30	1.30	1.40	1.30	1.40	1.40	0.80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Property Plant And Equipment Net		121.34	126.22	131.83	140.78	146.54	144.85	139.44	127.01	91.81	65.14	44.12	37.86	31.98	27.15	25.47	23.87	23.27	21.34	20.84	19.82	14.94	13.60	12.33	NA	NA	NA
Goodwill		85.81	85.81	85.81	85.81	85.81	85.81	85.81	85.81	85.68	84.24	22.43	22.68	1.14	1.14	1.14	1.14	1.14	1.14	1.14	1.14	1.14	1.14	1.14	NA	NA	NA
Finite Lived Intangible Assets Net		51.90	53.19	54.48	55.77	57.07	58.36	59.74	61.12	62.49	63.92	18.26	18.56	0.20	0.26	0.31	0.36	0.41	0.46	0.51	0.56	0.61	0.66	0.71	NA	NA	NA
Other Assets Noncurrent		5.39	5.42	5.68	6.02	2.20	2.92	3.38	3.87	6.90	7.42	7.67	5.26	3.45	2.73	2.82	2.65	2.42	2.24	3.80	2.09	1.91	1.82	5.36	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Liabilities Current		67.49	65.23	73.32	72.82	72.11	83.84	90.66	92.69	84.63	80.03	63.05	54.83	40.44	37.10	36.03	31.38	30.21	57.84	30.35	25.45	18.58	19.00	18.54	NA	NA	NA
Accounts Payable Current		7.70	9.26	14.05	12.18	13.24	20.11	20.09	21.01	16.82	23.07	14.90	11.27	8.53	8.93	4.83	5.97	6.93	9.11	9.76	7.83	4.50	6.72	7.53	NA	NA	NA
Taxes Payable Current		2.10	3.20	4.37	6.39	5.19	3.76	3.66	3.85	3.59	NA	2.44	NA	NA	NA	0.72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Accrued Liabilities Current		14.51	13.96	10.75	10.31	11.16	10.40	10.17	9.50	15.94	11.69	6.44	4.87	3.27	3.51	3.90	2.73	3.49	4.69	5.96	3.71	2.41	2.61	2.17	NA	NA	NA
Other Liabilities Current		5.44	6.42	7.80	9.91	10.04	15.82	19.74	20.12	16.02	13.86	9.62	9.27	4.06	3.31	2.61	1.37	0.05	1.00	0.82	0.68	0.89	1.07	0.94	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Other Liabilities Noncurrent		0.42	0.47	0.47	0.06	0.06	0.06	0.06	2.06	8.15	19.67	5.07	6.17	0.42	0.21	0.35	NA	0.10	0.14	0.16	0.24	0.28	0.33	0.34	NA	NA	NA
Operating Lease Liability Noncurrent		74.80	77.07	79.17	79.90	77.82	79.75	81.27	64.24	65.50	60.28	53.16	53.85	22.24	23.68	24.84	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Stockholders Equity		560.13	590.04	623.43	657.55	703.93	746.33	789.38	820.68	863.36	626.18	580.82	610.45	614.18	637.95	336.26	348.95	264.20	103.08	152.08	176.00	115.48	138.60	-201.42	-182.76	-165.72	-149.70
Additional Paid In Capital		1682.47	1666.80	1657.22	1644.98	1633.22	1617.17	1619.64	1599.36	1580.62	1281.93	1190.83	1179.33	1143.27	1129.16	794.63	782.95	669.92	477.05	470.43	463.23	375.04	372.07	9.35	NA	NA	NA
Retained Earnings Accumulated Deficit		-1121.68	-1076.19	-1033.03	-986.79	-929.40	-870.24	-828.42	-777.30	-716.78	-656.12	-610.55	-569.31	-529.27	-491.36	-458.45	-434.14	-405.93	-374.16	-318.52	-287.34	-259.43	-233.49	-210.85	NA	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		-0.66	-0.56	-0.76	-0.64	0.11	-0.61	-1.84	-1.38	-0.47	0.36	0.55	0.43	0.19	0.14	0.09	0.13	0.21	0.19	0.18	0.12	-0.14	0.02	0.09	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		13.85	11.05	11.80	10.66	10.43	-2.07	19.05	20.04	22.46	18.11	9.25	9.18	11.55	7.02	5.13	4.07	4.20	3.70	3.36	3.03	2.91	1.86	1.09	0.60	0.74	0.54

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Net Cash Provided By Used In Operating Activities		-19.42	-22.97	-20.70	-23.41	-44.29	-54.07	-1.27	-34.12	-42.34	-46.65	-34.80	-27.96	-24.55	-24.93	-25.20	-23.47	-58.67	-34.91	-23.36	-22.08	-20.81	-21.68	-16.70	-16.94	-16.51	-16.02
Net Cash Provided By Used In Investing Activities		-5.24	4.17	-2.25	18.67	41.16	-6.97	2.78	4.16	-13.29	-226.58	23.91	104.58	73.59	-45.92	-94.67	-61.15	28.76	12.40	-1.19	-22.71	-15.16	-65.76	0.40	4.58	14.11	8.21
Net Cash Provided By Used In Financing Activities		1.83	-1.47	0.44	-0.66	1.52	-0.40	1.24	-1.31	271.62	-1.01	1.57	-0.77	1.45	326.92	5.57	108.06	188.04	2.06	2.93	84.28	-1.63	73.00	6.58	24.83	54.75	2.66

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Net Cash Provided By Used In Operating Activities		-19.42	-22.97	-20.70	-23.41	-44.29	-54.07	-1.27	-34.12	-42.34	-46.65	-34.80	-27.96	-24.55	-24.93	-25.20	-23.47	-58.67	-34.91	-23.36	-22.08	-20.81	-21.68	-16.70	-16.94	-16.51	-16.02
Net Income Loss		-45.49	-43.01	-46.24	-57.40	-59.16	-41.82	-51.12	-60.52	-60.67	-45.56	-41.24	-40.04	-37.92	-32.90	-24.32	-28.21	-31.77	-55.64	-31.18	-27.92	-25.93	-22.64	-19.80	-17.62	-16.87	-16.94
Profit Loss		-45.49	-43.01	-46.24	-57.40	-59.16	-41.82	-51.12	-60.52	-60.67	-45.56	-41.24	-40.04	-37.92	-32.90	-24.32	-28.21	-31.77	-55.64	-31.18	-27.92	-25.93	-22.64	-19.80	-17.62	-16.87	-16.94
Depreciation Depletion And Amortization		8.30	8.17	8.50	8.49	7.03	5.29	4.95	4.44	3.97	3.15	2.43	2.74	2.46	2.11	1.89	1.72	1.56	1.50	1.49	1.59	1.56	1.47	1.33	1.70	1.42	1.29
Increase Decrease In Accounts Receivable		0.66	-8.06	1.81	-5.54	3.95	4.10	-0.66	6.44	1.81	2.03	0.29	0.58	2.21	-0.88	13.03	-1.48	1.78	0.95	0.58	3.53	1.02	1.56	1.13	0.27	0.99	0.68
Increase Decrease In Inventories		-0.49	-1.20	-4.29	-3.56	-4.67	5.28	-3.70	-1.55	4.35	8.44	10.57	5.37	2.42	1.12	-0.88	2.40	3.35	0.09	1.83	1.05	-1.11	-0.47	1.78	1.14	0.84	0.45
Increase Decrease In Accounts Payable		-1.52	-4.21	1.92	-0.22	-7.49	3.28	6.92	1.23	-0.76	-0.01	3.35	1.40	0.34	3.46	-1.69	-0.74	-2.52	-0.56	3.37	1.92	-1.30	-0.71	2.22	0.23	0.35	0.95
Share Based Compensation		13.82	11.02	11.75	10.60	10.26	-2.33	19.05	20.04	22.46	18.11	9.25	9.18	11.55	7.02	5.13	4.07	4.20	3.70	3.36	3.03	2.91	1.86	1.09	0.60	0.74	0.54

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Net Cash Provided By Used In Investing Activities		-5.24	4.17	-2.25	18.67	41.16	-6.97	2.78	4.16	-13.29	-226.58	23.91	104.58	73.59	-45.92	-94.67	-61.15	28.76	12.40	-1.19	-22.71	-15.16	-65.76	0.40	4.58	14.11	8.21
Payments To Acquire Property Plant And Equipment		0.60	1.51	2.39	4.51	9.05	11.82	16.46	40.64	31.97	12.78	8.09	6.94	8.40	3.63	2.23	2.85	2.74	2.06	3.89	5.17	3.77	1.92	1.05	0.63	0.50	1.51
Payments To Acquire Investments		10.64	18.33	18.09	7.82	27.79	22.65	0.00	0.00	0.00	217.64	0.00	0.00	-15.50	74.29	92.44	103.90	0.00	6.54	40.31	50.64	22.79	63.84	0.15	0.00	0.00	3.37

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Net Cash Provided By Used In Financing Activities		1.83	-1.47	0.44	-0.66	1.52	-0.40	1.24	-1.31	271.62	-1.01	1.57	-0.77	1.45	326.92	5.57	108.06	188.04	2.06	2.93	84.28	-1.63	73.00	6.58	24.83	54.75	2.66

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31
Revenues		75.30	71.50	66.95	63.74	60.18	54.24	57.31	56.11	48.13	42.02	37.95	35.02	31.20	28.16	32.43	21.21	19.30	17.16	15.74	13.60	13.56	11.49	8.41	6.54	6.17	4.31
Academic Research		13.72	13.77	12.29	12.42	11.12	10.02	10.22	9.50	9.48	7.89	7.00	7.75	5.65	4.90	5.30	4.62	5.54	NA	NA	NA	NA	NA	NA	NA	NA	NA
Food Or Agriculture		0.38	0.57	0.73	0.53	0.89	0.64	0.72	0.44	0.45	0.55	0.34	0.49	0.33	0.15	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Industrial Chemicals		20.26	16.28	14.54	16.80	14.41	13.57	14.41	16.73	14.08	12.53	9.26	9.42	8.66	7.13	7.58	7.70	7.54	NA	NA	NA	NA	NA	NA	NA	NA	NA
Health Care		40.93	40.88	39.38	33.99	33.76	30.01	31.95	29.44	24.11	21.05	21.34	17.36	16.56	15.98	19.18	8.55	5.75	NA	NA	NA	NA	NA	NA	NA	NA	NA
Antibody Discovery		4.70	5.23	3.39	4.58	7.03	8.17	6.53	6.24	6.59	4.81	2.61	1.99	1.28	1.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Dna And Biopharma Libraries		3.53	2.94	2.66	2.88	2.83	1.84	1.50	1.42	1.97	1.26	4.10	3.14	3.22	2.21	2.42	1.52	1.35	1.06	0.38	0.58	0.66	NA	NA	NA	NA	NA
Ngs Tools		40.77	39.42	37.11	33.24	28.99	24.36	29.19	27.79	23.10	19.23	21.45	18.70	16.95	15.57	20.18	9.08	7.73	7.03	6.18	5.57	5.54	3.76	0.91	0.97	NA	NA
Oligo Pools		3.94	4.19	3.74	3.73	3.31	3.70	3.67	3.26	2.31	3.19	2.67	2.02	1.84	1.51	1.20	1.00	1.10	1.24	1.31	1.21	1.26	0.81	0.86	0.81	0.61	0.73
Synthetic Genes		22.36	19.73	20.05	19.30	18.01	16.18	16.42	17.40	14.16	13.53	9.74	11.16	9.19	8.87	8.64	9.60	9.12	7.84	7.86	6.24	6.10	6.51	6.08	4.24	4.55	3.12
Related Party		3.20	2.30	2.30	0.90	2.20	0.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
		45.87	43.96	43.68	39.02	34.92	33.65	34.84	35.80	28.46	22.61	76.58	0.54	0.48	0.30	0.29	0.27	0.37	0.15	0.19	0.53	0.21	NA	0.05	0.06	0.04	NA
		7.17	6.32	6.06	5.66	6.47	4.27	5.60	4.83	4.46	4.04	2.77	3.10	2.67	1.77	1.75	1.18	0.94	1.24	0.74	0.88	0.72	0.42	0.26	0.27	0.32	0.15
EMEA		22.26	21.22	17.21	19.07	18.78	16.33	16.87	15.48	15.20	15.37	12.43	12.66	9.98	9.06	7.25	6.39	6.23	5.94	5.43	3.51	3.31	2.44	2.44	1.62	1.39	1.10
Revenue From Contract With Customer Including Assessed Tax		75.30	71.50	66.95	63.74	60.18	54.24	57.31	56.11	48.13	42.02	37.95	35.02	31.20	28.16	32.43	21.21	19.30	17.16	15.74	13.60	13.56	11.49	8.41	6.54	6.17	4.31
Academic Research		13.72	13.77	12.29	12.42	11.12	10.02	10.22	9.50	9.48	7.89	7.00	7.75	5.65	4.90	5.30	4.62	5.54	NA	NA	NA	NA	NA	NA	NA	NA	NA
Food Or Agriculture		0.38	0.57	0.73	0.53	0.89	0.64	0.72	0.44	0.45	0.55	0.34	0.49	0.33	0.15	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Industrial Chemicals		20.26	16.28	14.54	16.80	14.41	13.57	14.41	16.73	14.08	12.53	9.26	9.42	8.66	7.13	7.58	7.70	7.54	NA	NA	NA	NA	NA	NA	NA	NA	NA
Health Care		40.93	40.88	39.38	33.99	33.76	30.01	31.95	29.44	24.11	21.05	21.34	17.36	16.56	15.98	19.18	8.55	5.75	NA	NA	NA	NA	NA	NA	NA	NA	NA
Antibody Discovery		4.70	5.23	3.39	4.58	7.03	8.17	6.53	6.24	6.59	4.81	2.61	1.99	1.28	1.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Dna And Biopharma Libraries		3.53	2.94	2.66	2.88	2.83	1.84	1.50	1.42	1.97	1.26	4.10	3.14	3.22	2.21	2.42	1.52	1.35	1.06	0.38	0.58	0.66	NA	NA	NA	NA	NA
Ngs Tools		40.77	39.42	37.11	33.24	28.99	24.36	29.19	27.79	23.10	19.23	21.45	18.70	16.95	15.57	20.18	9.08	7.73	7.03	6.18	5.57	5.54	3.76	0.91	0.97	NA	NA
Oligo Pools		3.94	4.19	3.74	3.73	3.31	3.70	3.67	3.26	2.31	3.19	2.67	2.02	1.84	1.51	1.20	1.00	1.10	1.24	1.31	1.21	1.26	0.81	0.86	0.81	0.61	0.73
Synthetic Genes		22.36	19.73	20.05	19.30	18.01	16.18	16.42	17.40	14.16	13.53	9.74	11.16	9.19	8.87	8.64	9.60	9.12	7.84	7.86	6.24	6.10	6.51	6.08	4.24	4.55	3.12
Related Party		3.20	2.30	2.30	0.90	2.20	0.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
		45.87	43.96	43.68	39.02	34.92	33.65	34.84	35.80	28.46	22.61	76.58	0.54	0.48	0.30	0.29	0.27	0.37	0.15	0.19	0.53	0.21	NA	0.05	0.06	0.04	NA
		7.17	6.32	6.06	5.66	6.47	4.27	5.60	4.83	4.46	4.04	2.77	3.10	2.67	1.77	1.75	1.18	0.94	1.24	0.74	0.88	0.72	0.42	0.26	0.27	0.32	0.15
EMEA		22.26	21.22	17.21	19.07	18.78	16.33	16.87	15.48	15.20	15.37	12.43	12.66	9.98	9.06	7.25	6.39	6.23	5.94	5.43	3.51	3.31	2.44	2.44	1.62	1.39	1.10

Plots across concepts

Line plots across dimensions of each concept